Lista de obras - Kilannin Krysiak - Dominio Público Uruguay

A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer.

artículo científico publicado en 2017

A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation

artículo científico publicado en 2019

A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML.

artículo científico publicado en 2016

A genomic case study of mixed fibrolamellar hepatocellular carcinoma

artículo científico publicado en 2016

A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

artículo científico publicado en 2020

Abstract 2608: Global integration of knowledgebases for clinical interpretation of cancer variants

Activity of sulfonium bisphosphonates on tumor cell lines

artículo científico publicado en 2007

Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community-driven standards

artículo científico publicado en 2018

Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer

scientific article published in Nature Communications

Bisphosphonate inhibitors of ATP-mediated HIV-1 reverse transcriptase catalyzed excision of chain-terminating 3'-azido, 3'-deoxythymidine: a QSAR investigation

artículo científico publicado en 2008

CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer

artículo científico publicado en 2017

CIViC: A knowledgebase for expert-crowdsourcing the clinical interpretation of variants in cancer

CIViCpy: A Python Software Development and Analysis Toolkit for the CIViC Knowledgebase

scientific article published on 01 March 2020

Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia

artículo científico publicado en 2016

Corrigendum to "Haploinsufficiency of multiple del(5q) genes induce B cell abnormalities in mice" [Leuk. Res. 96C (2020) 106428]

artículo científico publicado en 2020

DGIdb 2.0: mining clinically relevant drug-gene interactions.

artículo científico publicado en 2015

Haploinsufficiency of multiple del(5q) genes induce B cell abnormalities in mice

artículo científico publicado en 2020

Heterozygous HMGB1 loss‐of‐function variants are associated with developmental delay and microcephaly

Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells

artículo científico publicado en 2017

Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice

scientific journal article

Lipophilic Bisphosphonates as Dual Farnesyl/Geranylgeranyl Diphosphate Synthase Inhibitors: An X-ray and NMR Investigation

artículo científico publicado en 2009

Lipophilic pyridinium bisphosphonates: potent gammadelta T cell stimulators

artículo científico publicado en 2010

Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.

artículo científico publicado en 2017

Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes

artículo científico publicado en 2019

Optimizing cancer genome sequencing and analysis

artículo científico publicado en 2015

Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer

artículo científico publicado en 2018

Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes

artículo científico publicado en 2011

Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.

artículo científico publicado en 2016

Reduced levels of Hspa9 attenuate Stat5 activation in mouse B cells

artículo científico publicado en 2014

Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial.

artículo científico publicado en 2017

Spontaneous aggressive ERα+ mammary tumor model is driven by Kras activation

Standard operating procedure for curation and clinical interpretation of variants in cancer

scientific article published on 29 November 2019

Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples

artículo científico publicado en 2018

Standard operating procedure for somatic variant refinement of tumor sequencing data

Text-mining clinically relevant cancer biomarkers for curation into the CIViC database

scientific article published on 03 December 2019

The prognostic effects of somatic mutations in ER-positive breast cancer

artículo científico publicado en 2018

Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas.

artículo científico publicado en 2016

Lista de obras de Kilannin Krysiak

A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer.

A Spontaneous Aggressive ERα+ Mammary Tumor Model Is Driven by Kras Activation

A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML.

A genomic case study of mixed fibrolamellar hepatocellular carcinoma

A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

Abstract 2608: Global integration of knowledgebases for clinical interpretation of cancer variants

Activity of sulfonium bisphosphonates on tumor cell lines

Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community-driven standards

Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer

Bisphosphonate inhibitors of ATP-mediated HIV-1 reverse transcriptase catalyzed excision of chain-terminating 3'-azido, 3'-deoxythymidine: a QSAR investigation

CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer

CIViC: A knowledgebase for expert-crowdsourcing the clinical interpretation of variants in cancer

CIViCpy: A Python Software Development and Analysis Toolkit for the CIViC Knowledgebase

Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia

Corrigendum to "Haploinsufficiency of multiple del(5q) genes induce B cell abnormalities in mice" [Leuk. Res. 96C (2020) 106428]

DGIdb 2.0: mining clinically relevant drug-gene interactions.

Haploinsufficiency of multiple del(5q) genes induce B cell abnormalities in mice

Heterozygous HMGB1 loss‐of‐function variants are associated with developmental delay and microcephaly

Knockdown of HSPA9 induces TP53-dependent apoptosis in human hematopoietic progenitor cells

Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice

Lipophilic Bisphosphonates as Dual Farnesyl/Geranylgeranyl Diphosphate Synthase Inhibitors: An X-ray and NMR Investigation

Lipophilic pyridinium bisphosphonates: potent gammadelta T cell stimulators

Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.

Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes

Optimizing cancer genome sequencing and analysis

Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer

Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes

Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.

Reduced levels of Hspa9 attenuate Stat5 activation in mouse B cells

Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial.

Spontaneous aggressive ERα+ mammary tumor model is driven by Kras activation

Standard operating procedure for curation and clinical interpretation of variants in cancer

Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples

Standard operating procedure for somatic variant refinement of tumor sequencing data

Text-mining clinically relevant cancer biomarkers for curation into the CIViC database

The prognostic effects of somatic mutations in ER-positive breast cancer

Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas.